Using Patients’ Own Immune System to Knock-out Cancer: Adoptive Cell Therapy
Bile Duct Cancer patient who received life expectancy of a couple of months will talk about how clinical trial saved her life – don’t miss live webinar! on Oct 21, 2014.
Sign up for webinar here: http://buff.ly/1z8jeHJ
Melinda Bachini was diagnosed in 2009. She is now 46 years old, and is a wife and a mother of six beautiful children. Now she can add brave, fierce and survivor to her name. In this live webinar, Melinda Bachini will share her journey through diagnosis and treatment as a cholangiocarcinoma (bile duct cancer) patient and study participant.
“I found myself not wanting to spend the rest of the life I had left using a chemo that would not cure me but had already caused so much damage. Chemo was toxic and it was not holding against this growing cancer within me.I found the NIH clinical trial online shortly after this decision.” Melinda Bachini
Also on webinar hear from Steven A. Rosenberg, M.D., Ph.D., National Cancer Institute, Adoptive Cell Therapy pioneer. Adoptive cell therapy uses a technique that harnesses a person’s own immune system to fight cancer & Eric Tran, Ph.D., National Institutes of Health Surgery Branch, Tumor Immunology Section